ALPHA TRIBE

Symbiox Investment & Trading Company LtdBoard Meeting, 06-08-2025: Board Meeting

06-08-2025 | 10:01 am

HY ‘ H 221, Rabindra Sarani, 3rd Floor Symbiox Investment & Trading Co. Ltd. Root NOt Keita 700 007

Contact : 98302 74227

CIN : L65993WB1979PLC032012

Website : www.symbioxinvestment.com

E-mail : symbioxinvestment10O0@gmail.com

Date: 06" August, 2025

To, To,

Compliance Department The Calcutta Stock Exchange Limited

Metropolitan Stock Exchange of India Limited 7, Lyons Range,

Vibgyor Towers, 4th floor, Plot No C 62,G- Bloc Kolkata- 700 001

Opp. Trident Hotel, Bandra Kurla Complex,

Bandra (5),

Mumbai -- 400 098

To,

The Bombay Stock Exchange Limited,

PJ Towers, Dalal Street

Mumbai- 400 001

Subject: Outcome of 2"! /2025-26 Board Meeting to be held on 06" August, 2025,

BSE Scrip Code: 539278 CSE Scrip Code: 029461 Symbol: SYMBIOX

Dear Sir,

We would like to inform you that the Meeting of Board of Directors of M/s. Symbiox Investment

& Trading Co Ltd was held on 06" August, 2025 Wednesday at 02:00 P.M. at its registered

office address to inter-alia transact the following matters:

1. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements)

Regulations, 2015, approved the Unaudited Financial Results for the quarter ended on

30 June, 2025.

2. Adopted Auditor’s Limited Review Report given by Statutory Auditor of the Company

for the quarter ended on 30" June, 2025.

3. No other matters was transacted at the meeting.

Kindly note that the meeting of the Board of Directors commenced at 02:00 P.M and concluded at

03:15 P.M.

Please take the same on your record and acknowledge the receipt of the same.

Thanking You.

Yours Faithfully,

----------------Page (0) Break----------------

SSR V & Associates

Chartered Accountants

INDIA

Independent Auditors’ Limited Review Report on quarterly unaudited standalone financial results of

Symbiox Investment & Trading Co Ltd pursuant to the Regulation 33 of the SEBI (Listing Obligations

and Disclosure Requirements) Regulations, 2015.

Review Report to

The Board of Directors,

Symbiox Investment & Trading Co. Limited

221, Rabindra Sarani, 3 Floor

Room No. 1, Kolkata-700007,

1. We have reviewed the accompanying statement of unaudited financial results of Symbiox Investment &

Trading Co. Limited (‘the Company’) for the quarter ended 30" June, 2025 (the "Statement") being

submitted by the Company pursuant to the requirement of Regulation 33 of the SEB] (Listing Obligations

and Disclosure Requirements’) Regulations, 2015.

This Statement which is the responsibility of the Company’s Management and approved by the Board of

Directors, has been prepared in accordance with the recognition and measurement principles laid down in

Indian Accounting Standard 34 “Interim Financial Reporting”? (“Ind AS 34”), prescribed under section 133 of

the Companies Act, 2013 (the Act”) read with relevant rules issued there under and other accounting

principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our

review.

2, We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, Review

of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Institute

of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain

moderate assurance as to whether the Statement is free of material misstatement. A review is limited

primarily to inquiries of company personne! and analytical procedures applied to financial data and thus

provide less assurance than an audit. We have not performed an audil and accordingly, we do not express an

audit opinion.

3. Based on our review conducted as above, nothing has come to our attention that causes us to

believe that the accompanying Statement of unaudited financial results prepared in accordance with applicable

accounting standards and other recognised accounting practices and poticies has not disclosed the information

required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015. including the manner in which it is to be disclosed, or that it contains any

material misstatement

For SS RV & Associates

Chartered Accountants

oh

\a~ LON ae is

VisAnu Kant Kabra 3: oe pee

Partner

Membership No.: 403437

Place: Mumbai

Date: 06 August, 2025

UDIN: 25403437BMIPJOS135

509, B-Wing, Express Zone, Off. Western Express Highway, Malad (E), Mumbai - 400 097. Maharashtra

E-mail: ssrvandassociates@gmail.com, sarvandassociates@ssrv.in | Tel: 022-47818886,87,88,89

----------------Page (1) Break----------------

SYMBIOX INVESTMENT & TRADING CO LTD

221, RABINDRA SARANI, 3RD FLOOR, ROOM NO-1, KOLKATA -700007

CIN - 165993WB1979PLC032012

Email - symbioxinvestment100@gmail.com; Website: www. symbioxinvestment.com

Satement of Unaudited Financial Result for the quarter ended 30th June, 2025

(Rupees in Lakh except EPS)

Particulars Quarter ended Year ended

30-06-2025 31-03-2025 30-06-2024 31-03-2025

Unaudited Audited Unaudited Audited

i |Revenue From Operations 45.81 124.50 31.23 276.36

{| |Other Income 0.19 0.39 0.00 0.43

ll Total Income (+11) 46.00 124.89 31.23 276,79

IV. [EXPENSES

Cost of materials consumed - - - 0.00

Purchases of Stock-in-Trade 9.48 175.02 47.24 332.12

Changes in inventories of finished goods,

Stock-in -Trade and work-in-progress 13.80 -18.46 ~34,.76 -120.68

Employee benefits expense 4.07 4.78 4.10 15.34

Finance costs - - - 0.00

Depreciation and amortization expense 0.07 0.07 0.07 0.29

Other expenses 9.54 3,94 13.83 23.79

Total expenses (IV) 36.96 165.35 30.48 250.86

Profit/(ioss) before exceptional items and

Vv |tax (I- 1V) 9.04 -40.46 0.75 25.93

VI |Exceptional Items - - - 0.00

Profit/(loss) before tax

vit |(V-VE) 9,04 -40.46 0.75 25.93

VII |Tax expense:

(1) Current tax 2.35 -10.52 0.19 6.74

(2) Deferred tax - - - 0.00

Profit (Loss) for the period from

IX Jcontinuing operations (VII-VIII) 6.69 -29.94 0.56 19.19

X |Profit/(loss) from discontinued operations - - - 0.00

X! |Tax expense of discontinued operations - - - 0.00

Profit/(loss) from Discontinued operations

XIL [after tax) (X-X!) 6.69 -29,94 0.56 19.19

XIIL |Profit/(loss) for the period (IX+XII) 6.69 -29.94 0.56 19.19

XIV [Other Comprehensive Income

A (i) Items that will not be reclassified to

profit or loss

(ii) Income tax relating to items that will

not be reclassified to profit or loss

----------------Page (2) Break----------------

B (i) Items that will be reclassified to

profit or loss - - - -

(ii) Income tax relating to items that will

be reclassified to profit or loss ~ - - -

Total Comprehensive Income for the

period (XHUI+XIV)(Comprising Profit

(Loss) and Other Comprehensive Income

XV_ |for the period) - - . - -

Paid up equity share Capital ( No. of Shares) 31287330 31287330 31287330 31287330

Face Value 10.00 10.00 10,00 10.00

Earnings per equity share (for continuing

XVI Joperation):

(1) Basic 0.021 -0.096 0.002 0.061

(2) Diluted 0.021 -0.096 0.002 0.061

Earnings per equity share (for discontinued

XVIF Joperation):

(1} Basic 0,000 0.000 0.000 0.000

(2) Diluted 0.000 0,000 0.000 0.000

Earnings per equity share(for discontinued

XVII |& continuing operations)

(1) Basic 0.000 0.000 0.000 0.000

(2} Diluted 0.000 0.000 0.000 0.000

Note:

4 |The above Unaudited financial results were reviewed by Audit Committee and approved by the Board of Directors

in their meeting held on 06/08/2025.

2 |The figures for the quarter on 30th June 2025 and 31 March 2025 are the balancing figures between audited

figures of the full financial years ended on 31 March, 2025 .

3 |The Statutory auditors of the Company have carried out a "Auditor's report" of the above results as per Regulation

33 of the SEB (Listing Obligation and Disclosure Requirement) Regulations, 2015.

The Company has adopted Indian Accounting standards (ind AS) with effect from 01" April, 2017 and accordingly,

4 |the above results have been prepared in accordance with the Companies (Indian Accounting Standard) Rules, 2015

prescribed under Section 133 of the Companies Act, 2013

5 The above results for the quarter ended 30th June, 2025 along with Auditor Report has been approved by the

Board of Directors of the Company.

The previous period figures have been regrouped wherever necessary.

6 There are no qualofication in the Audit Report issued by the Auditor

For and behalf of Board S$ INVESTMENT & TRADING CO LTD

SAI RAY

Managing Director

DIN No. 08406285

Place: Kolkata

Date: 06.08.2025

----------------Page (3) Break----------------

No comments yet. Be the first to comment!

All announcements from Symbiox Investment & Trading Company Ltd